AKT1 and Parkinson disease: Multi‐omics and biochemical techniques further reveal that chiral NPs interfere with the chemokine axis (CX3CL1/CX3CR1)‐NF‐κB‐NLRP3 and PI3K‐AKT signaling pathways, regulate communications between neurons, neural stem cells and microglia (“the three‐body problem”), and induce anti‐inflammatory efficacy of microglia mitochondrial energy metabolic reprogramming in PD.